Vimarsana
Biggest News Aggregation in the World

Page 29 - Human Genetics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Human Genetics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Human Genetics Today - Breaking & Trending Today

Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2023 Earnings Call Transcript - Vimarsana News

Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2023 Earnings Call Transcript

Operator: Good day, and welcome to the Bionano's Third Quarter 2023 Earnings Conference Call. Today's conference is being recorded.

Ambry Genetics Unveils at ASHG New Insights on the Use of Multiomic Testing in 43,000 Patient Study - Vimarsana News

Ambry Genetics Unveils at ASHG New Insights on the Use of Multiomic Testing in 43,000 Patient Study

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Nov 4, 2023--

Ambry Genetics Unveils at ASHG New Insights on the Use of Multiomic Testing in 43,000 Patient Study - Vimarsana News

Ambry Genetics Unveils at ASHG New Insights on the Use of Multiomic Testing in 43,000 Patient Study

Expanding the clinical use of RNA sequencing improves diagnostic yield, reduces inconclusive rates, and improves health equityALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics, a prominent leader in clinical genomic testing and a subsidiary of REALM IDx, Inc., unveiled at the American Society of Human Genetics (A...

Gene editing breakthrough could offer new hope for people with phenylketonuria - Vimarsana News

Gene editing breakthrough could offer new hope for people with phenylketonuria

Phenylketonuria (PKU) is a rare newborn genetic disease that impacts between 1 in 10,000 to 1 in 20,000 people, depending on the individuals' genetic ancestry. PKU causes an amino acid-;called phenylalanine (Phe)-;to build up in the bloodstream.

Glycomine Presents at ASHG 2023 Data from Ongoing Natural History Study with Insight into Genetic Mu - Vimarsana News

Glycomine Presents at ASHG 2023 Data from Ongoing Natural History Study with Insight into Genetic Mu

This study in 139 patients with PMM2-CDG represents the largest prospective natural history dataset with more than 300 patient-years of data collected to dateData from this study lay the groundwork for future investigations into potential genotype/phenotype correlationsThe data presented at ASHG 2023 explores the im...